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Abstract A regulatory interdependence of expression of proto-oncogenes and muscle 
specific genes observed in smooth muscle was examined in cardiac muscle during normal 
development and hypertrophy both in rats and humans. During normal development in rats, 
myosin light chain 2 expression is very low at prenatal stages, while c-fos expression starts 
from the early stages of embryonic development. In aorta constricted rats c-fos induction 
occurs within 30 min whereas myosin light chain 2 expression is sufficiently high only 
after 3 or 4 days of post operative period. In the case of humans, the expression of myosin 
light chain 2 as well as c-fos occurs at high levels during embryonic development. Similar 
results were obtained with tissue samples obtained from patients with cardiac abnormalities. 
Induction of the c-fos gene in cultured myocytes by 12-O-tetradeeanoylphorbol 13-acetate 
has no influence on the expression of myosin light chain 2. These studies were extended 
with studies on c-myc and β-myosin heavy chain gene expression which revealed a similar 
pattern of expression as that of c-fos and myosin light chain 2. These results have indicated 
that the expression of proto-oncogenes in cardiac muscle may be independently regulated 
from the expression of muscle specific genes. 
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1. Introduction 
Induction of cellular oncogenes has been proposed to regulate the transcription of 
several other genes. For example, the enhanced expression of c-fos gene which 
encodes a nuclear protein, acts as a "master switch" in controlling gene expression 
during differentiation and in response to external stimuli (Distel et al 1987). The 
activation of expression of proto-oncogenes such as c-myc and c-ras down regulates 
the expression of muscle specific genes (Olson et al 1987; Schneider et al 1987). 
It has been reported that, in c-ras transformed HOS cell lines, the smooth muscle 
myosin light chain 2 (MLC2) expression is specifically repressed (Kumar and Chang 
1992). Similarly in skeletal mvogenesis, activation of c-fos gene expression is 
associated with the inhibition of several muscle specific genes (Lassar et al 1989) 
whereas in cardiomyocytes, the induction of c-fos and c-jun by adrenergic agonists 
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is associated with the assembly of MLC2 (Iwaki et al 1990). This might be due 
to the positive regulation of c-fos on the specific regulatory factors which activate 
MLC2 gene expression. This is in contrast to the report of Goswami et al (1992) 
who have recently shown that, the expression of c-fos inhibits the transcriptional 
activity of chicken cardiac MLC2 promoter in cultured embryonic chicken cardiac 
muscle cells. 
The present study was carried out to examine whether expression of proto-oncogenes 
has any effect on the expression of muscle specific genes in cardiac muscle during 
normal development and during myocardial hypertrophy. Studies with normally 
developed heart in both rat and human revealed that, the induced expression of 
proto-oncogenes occurs independent of muscle specific genes. Further, these studies 
showed that, the induction of proto-oncogenes during the development of cardiac 
hypertrophy does not have any effect on muscle specific gene expression. These 
studies suggest that these two classes of genes may be differentially regulated in 
cardiac muscle during normal development and myocardial hypertrophy in both 
humans as well as experimental animals (rats). 
 
2. Materials and methods 
 
2.1 Tissue source 
 
To induce pressure overloaded hypertrophy of the hearts, albino rats of Wistar 
derived strains (120–130 g) were anesthetized with diethylether and the main ascending 
aorta constricted with a tantalum hemoclip (Edward Weck and Co. Cat. 
No. 523135) following the method of Rakusan and Poupa (1966) with minor 
modifications. Animals were killed at predetermined limes (0·5, 1,2,3,6, 12 and 24 
h) after operation. Sham-operated animals were subjected to an identical procedure 
except for placement of the hemoclip. The development of hypertrophy was calculated 
as per cent increase in the ratio of heart weight (wet weight) to body weight with 
respect to sham-operated controls (Meenakshi et al 1983). To investigate the 
developmental changes, hearts of 10 and 20 days old embryos and 7 and 14 days 
old neonates were examined. 
The 20 , 21, 2 3 and 28 week old human embryonic hearts were kind gift of Ms. 
Bonne Gisel, Paris, France. The atrial and ventricular biopsy tissues of cardiac 
patients with atrial septal defect (ASD) and tetralogy of Fallot were kind gift of 
Dr Μ S Valiathan, Director, Shree Chitra Thirunal Institute of Medical Sciences, 
Trivandrum. The autopsy samples for normal control were collected from healthy 
individuals who died due to road accident. 
 
2.2 Probes used 
 
cDNA fragments corresponding to the coding region of rat c-fos and c-myc genes 
were kind gifts from Prof. Μ A Q Siddiqui, Health Science Centre, Brooklyn, 
State University of New York, USA. Rat cardiac myosin heavy chain clone pcMHC5 
is a kind gift of Prof. Β Nadal Ginard. The 769 bp EcoRI fragment corresponding 
to the human cardiac MLC2 cDNA is of our own isolate. 
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2.3  RNA isolation and Northern analysis 
 
Total cellular RNA was isolated by the guanidium thiocyanate method of Chomczynski 
and Sacchi (1987). For Northern blot analysis 20 μg of total RNA was size 
fractionated in a 1·2% formaldehyde/agarose gel and transferred onto nylon membrane 
(Ausubel et al 1987). Hybridization was carried out as described in “Membrane 
transfer and detection methods” Amersham (1985). Prehybridization was performed 
in a solution containing 6 × SSC, 50% formamide, 5 × Denhart’s solution, 10% 
Dextran sulphate and 100 μg/ml heat denatured calf thymus DNA for 4 h at 42°C. 
Hybridization was carried out in the same solution with the addition of 105 cpm/ml 
32P-labelled probe for 18 h at 42°C. Probes were prepared using Amersham Nick 
translation kit. Membranes were washed twice at 42°C with 2 × SSC (saline sodium 
citrate) buffer and 0·1% SDS, twice at 42°C with 1 × SSC and 0·1% SDS, once at 
room temperature with 0·1 × SSC and 0·1% SDS, air dried and exposed to X-ray 
film for 48 h with an intensifying screen at – 70°C. 
 
2.4 Slot-blot analysis 
 
Different concentrations of total RNA were blotted onto the nylon membranes using 
BRL Hybri-slot blot apparatus. Hybridization was carried out as described earlier. 
The autoradiograms were subjected to a densitometric scan using an LKB Ultrascan 
XL. 
 
 
2.5 Isolation of nuclei 
 
Nuclei were isolated and purified following the method of Mariappan et al (1990). 
The ventricular tissue was minced and homogenized in 8 vol. of an ice cold 
homogenizing buffer (0·3 Μ sucrose, 0·01 Μ Tris.cl (pH 7·5), 0·01 Μ NaCl, 0·001 
Μ MgCI2, 0·005 Μ CaCI2 and 1 mM PMSF) using a motor driven Teflon homogenizer. 
The homogenate was filtered through four layers of cheese cloth and centrifuged 
at 1000 g for 10 min at 4°C. The crude nuclear pellet was purified by pelleting 
through a step gradient of 2·4 Μ and 1·6 Μ sucrose in TEN buffer [0·01 Μ Tris.cl 
(pH 7·5), 0·002 Μ EDTA and 0·01 Μ NaCI] at 90,000 g for 1 h at 4°C. The pellet 
was suspended in 1 Μ sucrose containing 0·001 Μ CaCI2 and washed twice with 
the same buffer by centrifugation at 11,000 g for 10 min at 4°C. 
2.6 In vitro RNA synthesis  
In vitro transcription assay was carried out according to Long and Ordahl (1988) 
with slight modifications. The reaction was carried out at 25°C for 20 min in a 
100 μl reaction volume containing 25 mM HEPES (pH 8) 1m Μ MnCI2, 10 mM 
MgCI2, 2·5 mM Mg(CH3COO)2, 10% (v/v) glycerol, 150 mM KCl, 12 mM BME, 
0·2 mM spermidine, 2·0 mM creatine phosphate, 30 μg creatine phosphokinase, 600 
μΜ each of ATP, GTP, and CTP, 60 μΜ UTP. 100 μCi [α-32P]UTP (3000 Ci/mmol) 
and 2 × 105 nuclei. The reaction was stopped by adding 100 μl of 0·5% SDS-10 
mM EDTA (pH 8) solution. RNA was extracted by phenol: chloroform (1:1) and 
ethanol precipitated. 
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2.7 Isolation and culturing of cardiomyocvtes 
 
Cardiomyocytes from the ventricles of sham-operated and 28% hypertrophied rats 
were isolated following the method of Nair and Gupta (1988). Ventricular tissue 
was minced in a petridish containing balanced salt solution (BSS) and transferred 
into a trypsinization flask containing a teflon magnetic bar, 10 ml of dissociation 
medium containing 0·3 mg/ml collagenase, 0·3 mg/ml trypsin, 1 mg/ml bovine serum 
albumin in Hank’s BSS and antibiotics (Penicillin 100 U/ml, gentamycin 50 μg/ml). 
Digestion was carried out for 15 min at 37°C on a magnetic stirrer at a very low 
speed. After incubation, tissue was allowed to settle and the supernatant containing 
dissociated cells was transferred to a sterile tube. This process was repeated once 
and the supernatant pooled together. To inactivate the proteolytic enzymes, equal 
volume of 10% fetal calf serum was added to the supernatant. The cells were 
pelleted by centrifuging at 2000 g for 5 min and washed twice with culture medium. 
Cells isolated from one heart were plated in a flask in 6 ml of culture medium 
containing 5% fetal calf serum and incubated at 37°C with 5% CO2. 
 
2.8 TPA treatment 
 
The cells were induced by the addition of TPA (in DMSO) to a final concentration 
of 100 ng/ml; control cultures received DMSO alone. After 24 h, RNA was isolated 
from the cultures following the method of Chomezynski and Sacchi (1987). 
 
3. Results 
 
3.1 Expression of MLC2 and c-fos in rat heart during development and in response 
to pressure overload 
 
We first examined the expression of MLC2 and c-fos gene in the ventricles in 
response to pressure overload induced by aortic constriction. The coding sequence 
of the human cardiac MLC2 (Wadgaonkar et al 1993) which has 92% homology 
with the amino acid sequence of rat ventricular MLC2 was used as probe. The 
specificity of the probe was checked by Northern blot analysis. Figure 1 shows 
the hybridization pattern of total RNA isolated from rat heart ventricle during 
pressure overloaded hypertrophy. The results indicate that the expression of MLC2 
is induced after 12 h of post operative period whereas that of c-fos is induced 
within 30 min, reaching a maximum expression of 11-fold at 6 h after aortic 
constriction. Thereafter the expression of c-fos begins to decline. In contrast. MLC2 
expression is high only after 3 or 4 days of post operative period (28% hypertrophy) 
(figure 2). 
Expression of c-fos gene has been shown in rat heart during early embryonic 
growth and normal development (Komuro et al 1988). To compare the expression 
of c-fos and MLC2 in ventricles during embryonic and normal development, the 
hybridization analysis using MLC2 and c-fos probes was carried out with the total 
RNA isolated from the hearts at different stages of embryonic and normal 
development. The results (figure 3) indicate a high level of expression of c-fos 
in both 10 and 20 days old embryonic heart that reaches a maximum of 36-fold 
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Figure 1. Expression of MLC2 and co-fos genes during development of cardiac hypertrophy 
in rats. 
Three different concentrations (3, 6 and 9 μg) of total RNA isolated from sham-operated 
and aorta constricted rat hearts during early post operative period were slot-blotted and 
hybridized with gene specific probes. The filters were autoradiographed for 48 h at –70°C. 
 
in 7 days old neonates when compared to the basal level expression in adult 
animal. 
During rat heart development, the MLC2 expression is undetectable at prenatal 
stages. After birth, it is induced to 5-fold more in 7 days old neonates than that 
of basal level of expression observed at further time points. This is in contrast to 
c-fos expression which starts from the early stages of embryonic development. Both 
c-fos and MLC2 are expressed at high levels at 7 days after birth. 
 
 
3.2 Expression of MLC2 and c fos in human heart during development and cardiac 
abnormalities 
 
In order to look for the expression of MLC2 and c-fos during embryonic human 
heart development, we examined by slot-blot analysis, the total RNA isolated from 
20, 21, 23 and 28 weeks old embryonic human heart, using the respective probes. 
The results indicate (figure 4) a detectable level of MLC2 expression in 20 week 
old embryo and a high level of expression in all the other stages analysed. Since 
the availability of human fetal heart samples at further stages is very limited, we 
analysed only these four stages. Detectable levels of expression of c-fos gene was 
observed in all the four different stages of embryonic human heart. While in adult 
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Figure 2. Northern analysis of MLC2 mRNA levels in sham-operated and 28% hypertrophied 
rat ventricles. 
About 25 μg of total RNA isolated from sham-operated and aorta constricted (28% 
hypertrophy) rat ventricles were resolved on a 1·2% formaldehyde/agarose gel. It was 
transferred to a nylon membrane and hybridized with 32P-labelled human cardiac MLC2 
cDNA probe. The filter was autoradiographed for 48 h at -70°C 
(A) Ethidium bromide stained gel. (B) Autoradiogram. 
Lane I: Sham-operated; Lane 2: 28% hypertrophy; → indicates the position of MLC2 
 messangers. 
 
heart, it dropped to basal level of expression. Thus, the expression of MLC2 as well as 
c-fos occur at considerably higher levels in the four different stages of
embryonic human heart. 
To check the levels of expression of MLC2 and c-fos in human hypertrophic 
hearts, ventricular and atrial biopsy tissues of patients with cardiac anomalies such 
as ventricular septal defect (VSD) with right ventricular obstruction or double 
chambered right ventricle [tetralogy of Fallot (TOF)] and atrial septal defect (ASD) 
were checked. In the ventricles and atria of these patients, accumulation of messengers 
for MLC2 is very high. The densitometric scanning profile of the autoradiogram 
revealed a maximum of 8-fold increase in MLC2 hybridization in the ASD sample 
while only 4-fold increase in the diseased ventricular sample. Although the level 
of induction vary among the atrial and ventricular tissues of the patients with ASD 
or TOF, it is higher than the respective normal tissue samples (figure 5). The 
variation of induction within the tissues may be due to variation in the degree of 
hypertrophy. 
Similarly, in the case of c-fos also the level of expression is high in both 
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Figure 3. Expression of MLC2 and c-fos genes during rat heart development. 
Total RNA isolated from 10 and 20 days old embryonic rat hearts and 7 and 14 days 
old neonatal rat hearts were slot-blotted and hybridized with MLC2 and c-fos RNA specific gene 
probes. The filters were autoradiographed for 48 h at -70°C. 
 
ventricular and atrial tissues of cardiac patients (figure 5). The densitometry scanning 
of the autoradiogram revealed that the hybridization signals of ASD and VSD 
samples were respectively 3- to 7-fold more intense than that of control samples. 
Here again the intensities of signals varied between atrial and ventricular samples 
and the intensities of signals are high with RNA isolated from ventricular tissues 
of patients with TOF. 
 
3.3 Effect of TPA on the expression of MLC2 and c -fos in cultured hypertrophied 
adult cardiomyocytes 
 
The expression of MLC2 and c-fos in the cultured hypertrophied adult cardio- 
myocytes were studied in the presence and absence of a tumor promotor, 
12-O-tetradecanoyl phorbol 13-acetate (TPA) (100 ng/ml). Myocytes isolated from 
the ventricles of normal and 28% hypertrophied rats were treated with TPA (100 
ng/ml of culture medium) for 24 h. Total RNA was isolated, slot blotted and 
probed with c-fos and MLC2 specific gene probes. The results indicated that induced 
expression of MLC2 in the myocytes from 28% hypertrophied ventricle was not 
affected by TPA treatment in culture (figure 6). Also, it induced the expression of c-fos 
in both the normal and hypertrophied myocytes. These results have suggested that the 
induction of c-fos has no influence on the expression of MLC2 in cardiac muscle. 
 
3.4 Expression of c-myc and myosin heavy chain during cardiac hypertrophy 
 
In order to look for the expression of an another oncogene and a muscle specific 
gene during cardiac hypertrophy, total RNA isolated from rat hearts at different 
162 G Jegadeesh Babu et al 
 
 
Figure 4. Expression of MLC2 and c-fos genes during human heart development. 
Total RNA isolated from 20,21.23 and 28 weeks old human embryonic hearts were 
blotted as 3,6 and 9 μg and hybridized with 32P-labelled MLC2 and c-fos RNA specific 
gene probes. The filters were autoradiographed for 72 h at -70°C 
 
stages of hypertrophy were hybridized with c-myc and myosin heavy chain (MHC) 
specific gene probes. The results of hybridization analysis (figure 7A and 7C) 
showed an increased level of expression of c-myc messengers at 2 h after aortic 
constriction, with a drop in the expression to undetectable level at later stages of 
hypertrophy (40% hypertrophy). On the other hand, the accumulation of MHC 
messages, occurred gradually with considerably high levels at 40% of hypertrophy 
(figure 7B and 7C). Hybridization analysis of labelled RNA transcribed in vitro 
during transcription in isolated nuclei from hearts obtained at different stages of 
hypertrophy, with the above probes, showed an exactly similar pattern of increase 
as observed in the cytoplasmic accumulation (figure 8). 
 
4. Discussion 
 
Proto-oncogenes such as c-myc, c-fos and c jun have been shown to encode known 
or putative transcriptional factors and have been proposed to orchestrate different 
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Figure 5. Expression of MLC2 and c-fos genes in atrial and ventricular tissue samples 
obtained from patients with cardiac disorders. 
Total RNA isolated from atrial and ventricular biopsy samples obtained from patients 
with ASD or VSD were blotted as 3,6 and 9 μg and hybridized with MLC2 and c-fos 
RNA specific gene probes. The filters were autoradiographed for 48 h at -70°C. 
 
programs of gene expression in various differentiated cell types. Expression of 
proto-oncogenes up or down regulates several other genes. Recent studies have 
implicated, the c-fos/c jun heterodimers activating phorbol inducible genes such as 
|human collagenase gene and human metallothionein IIA (hMTIIA) gene (Lee et
al 1987 following binding to a consensus AP. 1 site in the promoter region of
these genes. c-fos induction during seruin stimulation is mediated by serum response 
element (SRE) (Treisman 1986) which has homology with cArG element within
the cardiac and skeletal α-actin genes that play a critical role in their muscle
specific expression (Sartorelli et al 1990; Taylor et al 1988). In c-ras trasformed
HOS cell lines the smooth muscle MLC2  expression is specifically repressed (Kumar
and Chang 1992). Similarly, expression of oncogenes like v-src, v-myc, c-myc,
v-erbA and .-ras can inhibit terminal differentiation of muscle cells to varying
extent (Falcone et al 1985; Olson et al 1987; Payne et al 1987; Schneider et al
1987). In a recent report (Goswami et al 1992) the inhibition of MLC2 promoter
has been attributed to the elevated levels of fos in cultured chicken cardiomyocytes.
In primary skeletal muscle cells, induction of c-fos gene by phorbol ester lead to
a selective disassembly of the myofibrillar apparatus and inhibition of the expression
of myofibrillar genes (Cohen et al 1977). In proliferating transformed myoblast,
the activated ras or fos not only inhibits muscle specific markers like MHCs, MLC
but also inhibit the expression of the myoblast lineage markers such as MyoDl,
MyoH and myogenin (Lassar et al 1989). In contrast, fos/jun expression in cardiac
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Figure 6. Slot blot hybridization analysis of MLC2 and c-fos gene expression in the 
cultured primary cardiomyocytes treated with TPA. 
Primary cultures of cardiomyocytes isolated from the sham-operated and 28% hypertrophied 
rat ventricles were treated with TPA (100 ng/ml) for 24 h and the RNA was isolated. It 
was blotted as two different concentrations (3 and 6 μg) and hybridized with MLC2 and 
c-fos RNA specific gene probes. The filters were autoradiographed for 4 days at –70°C. 
S, Sham-operated; S/TPA, Sham-operated, TPA treated. H, 28% hypertrophy; H/TPA, 28% 
hypertrophy, TPA treated. 
 
muscle cells by adrenergic agonists is associated with the assembly of MLC2 into 
organised contractile units (Iwake et al 1990). An increase in the transcription of 
protoncogenes like c-myc, c-fos and c-ras has been detected in the ventricle of 
rats during early stage of pressure overloaded hypertrophy (Izumo et al 1988; 
Komuro et al 1988). The upregulation of MLC2 has also been observed during 
hypertrophy in both human and rats (Kumar et al 1986; Cummins 1983). Although, 
the role of proto-oncogenes on the regulation of several other genes have been 
reported their role in the induction of contractile protein gene in cardiac muscle during 
normal development and hypertrophy is not known. 
Our present observations indicated a low level expression of a contractile protein 
(MLC2 gene) gene during rat heart development. In human heart development its 
expression is detected as early as 20W old embryonic heart. Similarly, the c-fos 
expression is at detectable levels at early embryonic stages and it gradually increased 
during development in rat as well as in human. High level of expression of either 
fos or MLC2 does not exclude the expression of the other. A similar coexpression 
is observed in the case of rat also, as c-fos and MLC2 are expressed at maximal 
levels in 7 days old neonates. This may be because of cellular hypertrophy which 
leads to increase in the volume and myofibrillar protein content of individual 
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Figure 7. (A) Expression of c-myc gene during the development of cardiac hypertrophy
in rats. 
Total RNA isolated from sham-operated (A) and aorta constricted (B 1 h, C 2 h, D 3 
h. Ε 24 h and F 40% hypertrophy) rat hearts were slot-blotted (I 3 μg. II 6 μg and III 9 
µg) and hybridized with c-myc specific gene probe. 
(B) Expression of MHC gene during the development of cardiac hypertrophy in rats. 
Total RNA isloated from sham-operated (I) and aorta constricted (II 1 h. III 2 h, IV 3 
h, V 24 h and VI 40% hypertrophy) rat hearts were slot-blotted (A 3 μg and Β 6 μg) and 
hybridized with MHC specific gene probe. 
(C) Relative accumulation of MHC and c-myc RNAs during the development of cardiac 
hypertrophy in rats. 
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Figure 8. (A) Expression of MHC and c-myc genes during the development of cardiac 
hypertrophy in rats. 
The myosin heavy chain (III) and c-myc cDNA (II) fragments and pBR 322 control 
plasmid DNA (I) (about 1 µg each) were immobilized on a nylon filter and hybridized 
with the 32P-labelled RNA transcribed in vitro from sham- operated (0h) and different 
stages of hypertrophic heart nuclei [ 1.2.3 and 24 h and 40% (12 days)]. 
(B) Relative level of in vitro transcription of MHC and c-myc RNA from isolated heart 
nuclei. 
(A) was scanned at 633 nm using a LKB ultrasean. The relative peak area for each sample 
is represented as bar. 
 
myocytes after 4th day of neonatal development (Grove et al 1969; Rumuyantsev 
1977). Atrial and ventricular tissues obtained from human patients with cardiac 
disorders showed greater levels of both c-fos and MLC2 expression than their 
respective normal tissues. 
It has been proposed that alteration of gene expression by ΤPA involves a 
cascade of events triggered by the action of protein kinase C (Nishizuka 1984) 
which may lead to modifications of specific transcriptional components. Expression 
of c-fos and activator protein 1 (API) has been reported to be modulated by TPA 
(Muller et al 1985; Lee et al 1987). Treatment of “HOS” cells with TPA resulted 
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in repression in the levels of smooth muscle MLC2 mRNA (Kumar and Chang 
1992). In contrast, Nag and Lee (1992) have recently demonstrated that the MHC 
isoform profiles of adult ventricular cardiomyocytes exposed to TPA at concentrations 
50-250 μg/mol culture medium for varying periods were similar to those of controls 
that were grown in the absence of TPA. We have shown here the c-fos induction 
by TPA has no influence in the induced expression of MLC2 in the hypertrophied 
cardiomyocytes. 
Similar results obtained with c-myc and MHC gene expression during 
pressure-overloaded cardiac hypertrophy in rats, further corroborate our observations. 
Falcone et al (1985) reported that v-myc expression in avian cells transformed by 
myelocytomatosis virus MC29, inhibits the myogenesis. In contrast, continuous 
c-myc gene transcription and high cytoplasmic levels of its mRNA did not have 
any detectable effect on the transcription of muscle specific genes and their 
accumulation (Endo and Nadal-Ginard 1986). In a contradicting report, the constitutive 
expression of c-fos is unable to activate MLC2 promotor linked luciferase reporter 
genes in co-transfection studies and this is attributed to the loose API motif present 
in cardiac MLC2 gene. Whereas the promoter containing multimeric API sites is 
induced to 50-fold (Knowlton et al 1991). Similarly, co-transfection assays in 
cardiac myocytes demonstrated that over expression of c jun or c-fos plus c jun 
transactivated the skeletal α-actin promoter (Bishopric et al 1992). Our 
immunoprecipitation data (presented elsewhere) on the levels c-fos and c jun protein 
which is very high during 7 days and 20 days old neonates and that of MLC2 
expression which is already at the basal level of expression in 14 days old neonates-
further strengthens our view on the independent regulation of proto- oncogenes and 
muscle specific genes in cardiac muscles. These observations along with our present 
results suggest that the expression of proto-oncogenes in cardiac muscles may not 
necessarily be an essential requirement for muscle specific gene activation and the 
muscle specific genes and proto-oncogenes may be independently regulated. 
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